← back to database
NYBC Ventures is the $50M venture fund established by New York Blood Center Enterprises. It targets early- to mid-stage innovations in hematology, transfusion medicine, cell therapy, infectious disease, and supporting blood and cellular-therapy technologies.
Stage focus
Specialization
Generalist / Specialist
Specialist
Latest fund size
$50M commitment
Investing team
Christopher D. HillyerGeneral Partner, Manager
Jay MohrGeneral Partner, Manager
Kuan YuSenior Analyst
Meg WoodManaging Director